{"id":11275,"date":"2025-07-27T03:23:44","date_gmt":"2025-07-27T01:23:44","guid":{"rendered":"https:\/\/valintermed.com\/?p=11275"},"modified":"2025-07-27T03:23:44","modified_gmt":"2025-07-27T01:23:44","slug":"fetalnyy-gidantoinovyy-sindrom","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/fetal-gidantoin-syndrome\/","title":{"rendered":"Fetal hydantoin syndrome"},"content":{"rendered":"
<\/div>\n

Fetal hydantoin syndrome (FHS) is a complex of congenital anomalies caused by prenatal exposure to hydantoin and its derivatives, often used as antiepileptic drugs. The main manifestations of this syndrome are characteristic physical abnormalities, including anomalies of the hands and limbs, craniofacial deformities, and mental retardation. This pathology belongs to the group of drug-induced disorders and manifests itself as a result of the effect of ternogenic factors on the developing fetus in the first trimester of pregnancy.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n